Order Article Reprints

Tinsley HN, Mathew B, Chen X, Maxuitenko YY, Li N, Lowe WM, Whitt JD, Zhang W, Gary BD, Keeton AB, et al. Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats. Cancers. 2023; 15(3):646. https://doi.org/10.3390/cancers15030646

Tinsley, Heather N., Bini Mathew, Xi Chen, Yulia Y. Maxuitenko, Nan Li, Whitney M. Lowe, Jason D. Whitt, Wei Zhang, Bernard D. Gary, Adam B. Keeton, and et al. 2023. "Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats" Cancers 15, no. 3: 646. https://doi.org/10.3390/cancers15030646

Tinsley, H. N., Mathew, B., Chen, X., Maxuitenko, Y. Y., Li, N., Lowe, W. M., Whitt, J. D., Zhang, W., Gary, B. D., Keeton, A. B., Grizzle, W. E., Grubbs, C. J., Reynolds, R. C., & Piazza, G. A. (2023). Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats. Cancers, 15(3), 646. https://doi.org/10.3390/cancers15030646